Evidence map›Paper›PMID 25275119›Full record

ArticleJournal of virology2014

Role of Mason-Pfizer monkey virus CA-NC spacer peptide-like domain in assembly of immature particles.

Karolína Strohalmová-Bohmová, Vojtěch Spiwok, Martin Lepšík, Romana Hadravová, Ivana Křížová, Pavel Ulbrich, Iva Pichová, Lucie Bednárová, Tomáš Ruml, Michaela Rumlová

Abstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Maturation of retroviruses.Current opinion in virology · 2019
    Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Karolína Strohalmová-BohmováInstitute of Organic Chemistry and Biochemistry IOCB Research Centre and Gilead Sciences, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nam. 2, 166 10, Prague 6, Czech Republic Department of Biochemistry and Microbiology, Institute of Chemical Technology, Technická 5, Prague, Czech Republic.
Vojtěch SpiwokDepartment of Biochemistry and Microbiology, Institute of Chemical Technology, Technická 5, Prague, Czech Republic.
Martin LepšíkInstitute of Organic Chemistry and Biochemistry IOCB Research Centre and Gilead Sciences, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nam. 2, 166 10, Prague 6, Czech Republic.
Romana HadravováInstitute of Organic Chemistry and Biochemistry IOCB Research Centre and Gilead Sciences, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nam. 2, 166 10, Prague 6, Czech Republic.
Ivana KřížováInstitute of Organic Chemistry and Biochemistry IOCB Research Centre and Gilead Sciences, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nam. 2, 166 10, Prague 6, Czech Republic.
Pavel UlbrichDepartment of Biochemistry and Microbiology, Institute of Chemical Technology, Technická 5, Prague, Czech Republic.
Iva PichováInstitute of Organic Chemistry and Biochemistry IOCB Research Centre and Gilead Sciences, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nam. 2, 166 10, Prague 6, Czech Republic.
Lucie BednárováInstitute of Organic Chemistry and Biochemistry IOCB Research Centre and Gilead Sciences, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nam. 2, 166 10, Prague 6, Czech Republic.
Tomáš RumlDepartment of Biochemistry and Microbiology, Institute of Chemical Technology, Technická 5, Prague, Czech Republic tomas.ruml@vscht.cz rumlova@uochb.cas.cz.
Michaela RumlováInstitute of Organic Chemistry and Biochemistry IOCB Research Centre and Gilead Sciences, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nam. 2, 166 10, Prague 6, Czech Republic Department of Biotechnology, Institute of Chemical Technology, Technická 5, Prague, Czech Republic tomas.ruml@vscht.cz rumlova@uochb.cas.cz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledThe hexameric lattice of an immature retroviral particle consists of Gag polyprotein, which is the precursor of all viral structural proteins. Lentiviral and alpharetroviral Gag proteins contain a peptide sequence called the spacer peptide (SP), which is localized between the capsid (CA) and nucleocapsid (NC) domains. SP plays a critical role in intermolecular interactions during the assembly of immature particles of several retroviruses. Published models of supramolecular structures of immature particles suggest that in lentiviruses and alpharetroviruses, SP adopts a rod-like six-helix bundle organization. In contrast, Mason-Pfizer monkey virus (M-PMV), a betaretrovirus that assembles in the cytoplasm, does not contain a distinct SP sequence, and the CA-NC connecting region is not organized into a clear rod-like structure. Nevertheless, the CA-NC junction comprises a sequence critical for assembly of immature M-PMV particles. In the present work, we characterized this region, called the SP-like domain, in detail. We provide biochemical data confirming the critical role of the M-PMV SP-like domain in immature particle assembly, release, processing, and infectivity. Circular dichroism spectroscopy revealed that, in contrast to the SP regions of other retroviruses, a short SP-like domain-derived peptide (SPLP) does not form a purely helical structure in aqueous or helix-promoting solution. Using 8-Å cryo-electron microscopy density maps of immature M-PMV particles, we prepared computational models of the SP-like domain and indicate the structural features required for M-PMV immature particle assembly. IMPORTANCE: Retroviruses such as HIV-1 are of great medical importance. Using Mason-Pfizer monkey virus (M-PMV) as a model retrovirus, we provide biochemical and structural data confirming the general relevance of a short segment of the structural polyprotein Gag for retrovirus assembly and infectivity. Although this segment is critical for assembly of immature particles of lentiviruses, alpharetroviruses, and betaretroviruses, the organization of this domain is strikingly different. A previously published electron microscopic structure of an immature M-PMV particle allowed us to model this important region into the electron density map. The data presented here help explain the different packing of the Gag segments of various retroviruses, such as HIV, Rous sarcoma virus (RSV), and M-PMV. Such knowledge contributes to understanding the importance of this region and its structural flexibility among retroviral species. The region might play a key role in Gag-Gag interactions, leading to different morphological pathways of immature particle assembly.

Indexed as

Virus AssemblyCapsid ProteinsCircular DichroismCryoelectron MicroscopyMason-Pfizer monkey virusModels, MolecularNucleocapsid ProteinsProtein ConformationVirus ReleaseCapsid ProteinsNucleocapsid Proteins

Identifiers

PMID25275119
PMCPMC4249148

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.